🔎 Trials Near Me

Akèy › Kansè Urojenital › Maryland

Etid klinik pou Kansè Urojenital nan Maryland

8 etid pou Kansè Urojenital ap chèche patisipan nan sit nan Maryland.

Tèks ofisyèl etid la (Anglè)

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

  • Christiana Care - Union Hospital, Elkton
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07215624

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

  • National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 2
Laj 18 a 72 · Tout sèks · Mizajou Oct 2, 2026 · NCT01174121

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • National Institutes of Health Clinical Center, Bethesda
  • FMH James M Stockman Cancer Institute, Frederick
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

  • Chesapeake Urology, Baltimore
  • Johns Hopkins Medical Center, Baltimore
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05874921

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

  • National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 2
Laj 18 a 72 · Tout sèks · Mizajou Sep 28, 2026 · NCT03412877

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • National Institutes of Health, Bethesda
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT05592626

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

  • National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT04923178

Gender Related Coping and Survivorship for Genitourinary Cancers

  • Johns Hopkins Hospital, Baltimore
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Fanm · Mizajou Oct 3, 2025 · NCT05649306

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.